Suppressor of cytokine signaling protein (SOCS)

"Inhibitory cytokine signaling" is not a specific molecule or receptor but rather describes a biological process by which the effects of cytokines are negatively regulated within cells. The most well-characterized molecular mediators of inhibitory cytokine signaling are the suppressor of cytokine signaling (SOCS) proteins. These proteins are rapidly induced upon stimulation by various cytokines and act as feedback inhibitors to block further signal transduction through pathways such as Jak/Stat. SOCS1 and SOCS3, in particular, play essential roles in dampening inflammatory responses and maintaining immune homeostasis by inhibiting excessive activation from their target receptors[1][3]. Dysregulation or mutation in components involved in inhibitory cytokine signaling can contribute to diseases such as chronic inflammation, autoimmune disorders, and cancer[1]. However, "inhibitory cytokine signaling" itself is not a single druggable target but refers to this regulatory mechanism; thus it is not appropriate to treat it as a canonical therapeutic target like an enzyme or receptor. Note on correctness ("is_incorrect"): The term "Inhibitory cytokine signaling" does not refer to one specific molecule or receptor but rather a process involving several regulatory proteins (primarily the SOCS family). For structured data purposes, this entry should be flagged for correction—ideally replaced with "Suppressor of cytokine signaling protein" (SOCS) if referring specifically to these negative regulators[1][3].

Other names

Suppressors of cytokine signalingSOCS proteinsCytokine-induced inhibitors